-690x550.jpg)
THURSDAY, Sept. 12, 2024 (HealthDay News) — It could be a real breakthrough for people at risk for HIV infection: A shot given every six months that reduces their risk by a whopping 96%. That’s according to new trial results released Thursday by Gilead Sciences, which is repurposing its HIVContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — An ingredient in the hair dye a French woman used caused her to develop a vision-robbing retinopathy, researchers report. When she switched to a dye without these ingredients, called aromatic amines, her vision troubles resolved, according to a team led by Dr. NicolasContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Prescriptions for amphetamine stimulants to treat ADHD have increased significantly in recent years, particularly during the pandemic. Unfortunately, high doses of stimulants like Adderall can increase the risk of psychosis or mania by more than fivefold, a new study finds. Patients had aContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — The number of Americans with a potentially dangerous heart rhythm condition is three times greater than previously thought, a new study claims. An estimated 5% of the population — 10.5 million U.S. adults — have atrial fibrillation, according to new estimates from theContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide consistently reduced weight in both women and men, researchers found. ButContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds. More than one-third of those polled (37%) said they’d gotten vaccines in the past but don’t plan to this year, according to results from aContinue Reading
THURSDAY, Sept. 11, 2024 (HealthDay News) — Two monoclonal antibody treatments to slow Alzheimer’s disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years. It’s thought the drugs curb Alzheimer’s by reducing levels of toxic amyloid protein plaques inContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Black stroke victims are arriving at emergency rooms much later than white patients, greatly increasing their risk of death or lifelong disability, a new study finds. Every second counts when it comes to treating a stroke, experts say. Any moment’s delay allows forContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows. The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it forContinue Reading
THURSDAY, Sept. 12, 2024 (HealthDay News) — Less than half of people who’ve survived a stroke will go on to have a healthy, normal sleep pattern, new research shows. Normal sleep is defined as six to eight hours of shuteye nightly. However, a majority of the nearly 1,600 stroke survivorsContinue Reading